This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

McCune-Albright syndrome

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Albright-McCune syndrome is characterised by:

  • cafe au lait spots - more precisely Coast of Maine lesions, describing the less sharp edges of the patches
  • cystic bone lesions - polyostic fibrous dysplasia
  • precocious puberty
  • other possible findings include renal phosphate wasting and hyperfunctioning endocroninopathies e.g. acromegaly, hyperthyroidism, Cushing's syndrome

The underlying problem is with a mutation in the intracellular messanger G protein:

  • in patients with this condition the underlying defect consists of post-zygotic activating mutations in the GNAS1 gene - this gene codes for the alpha subunit of the signalling G protein
  • this alpha subunit causes ligand-dependent activation of cAMP signalling pathway and results in cellular hyperfunction, and in some cases hyperplasia
    • affected tissues in patients with McCune-Albright syndrome have a mutation of the G3a subunit of the G3 protein that activates adenylate cyclase
      • this activating mutation leads to continued stimulation of endocrine function, eg, precocious puberty

Patients with McCune-Albright syndrome are phenotypically somatic mosaics. This is because the mutation is post-zygotic.

Reference:

  • (1) Lancet 2001;357 (9273): 2011.
  • (2) Saenger P, Rincon M.Precocious puberty: McCune-Albright syndrome and beyond.J Pediatr. 2003 Jul;143(1):9-10.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.